2020-11-13T12:11:02-08:00 2019-12-31 390919055 Ritz Holman LLP 330 E Kilbourn Ste 550 Milwaukee WI 532023144 990 2019-01-01 911766321 THE AMERICAN SOCIETY OF GENE & CELL THERAPY AMER 4142781341 20800 Swenson Dr Waukesha WI 53018 PALOMA H GIANGRANDE PHD Treasurer 2020-11-13 true KATY L SOMMER P00273273 4142711451 2019 2021-01-29 14:40:06Z X PALOMA H GIANGRANDE PHD 20800 Swenson Dr 300 Waukesha WI 53018 6509265 false X WWW.ASGCT.ORG X 1996 WA ASGCT's mission is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. 14 14 0 14 25200 22725 982703 1124475 3849165 5227852 60563 100334 37837 56604 4930268 6509265 318536 388630 0 3000 8495 0 0 3076003 4294717 3397539 4691842 1532729 1817423 7087668 9695835 1074353 1394198 6013315 8301637 X ASGCT's mission is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. false false 2052159 88630 2135567 Annual Meeting: This is the Primary Vehicle for Carrying out the Educational Mission of ASGCT. The Annual Meeting Represents the Major Educational Initiative of the Society. 850632 300000 304070 Other programs include: Gene Editing Workshop, Cell Therapy Workshop, Commercialization Workshop, Clinical Trials Training Course, Policy Summit, Career Development Program, Patient Education Program, and the Newsletter. 462039 1780979 Molecular Therapy Journals: Publishing scholarly journals is the second major vehicle for carrying out the educational mission of ASGCT. The journals are the way ASGCT educates and updates researchers, clinicians, and students on the latest advances in the development of novel therapeutics. 242486 3607316 true true false false false false false false false true true false false false true true true false false false true false true false false false false true true false false false false false false false false false false false false false false false false false false true 50 0 true 0 true true false false false false false false 0 false false false false false false false X 14 14 false true false false true true true true true false false true true true true true true true true false X EXECUTIVE DIRECTOR INC 4142766445 555 EAST WELLS ST MILWAUKEE WI 53202 PALOMA H GIANGRANDE PHD Director 3.00 0.00 X 3720 0 0 BEVERLY DAVIDSON PHD Vice President 5.00 0.00 X X 3375 0 0 ISABELLE M RIVIERE PHD Director 3.00 0.00 X 1400 0 0 STEPHEN J RUSSELL MD PHD President-Elect 5.00 0.00 X X 0 0 0 MATTHEW WILSON MD PHD Director 3.00 0.00 X 0 0 0 JENNIFER E ADAIR PHD Director 3.00 0.00 X 0 0 0 PHILIP GREGORY DPHIL Director 3.00 0.00 X 0 0 0 MARITZA MCINTYRE PHD Director 3.00 0.00 X 0 0 0 TERRENCE R FLOTTE MD Secretary 5.00 0.00 X X 0 0 0 SEPPO YLA-HERTTUALA MD PHD Ex-Officio 3.00 0.00 X 0 0 0 STEPHEN L HART PHD Director 3.00 0.00 X 0 0 0 J KEITH JOUNG MD PHD Director 3.00 0.00 X 0 0 0 RICHARD MORGAN PHD Director 3.00 0.00 X 0 0 0 GUANGPING GAO PHD President 5.00 0.00 X X 0 0 0 PAULA M CANNON PHD Treasurer 5.00 0.00 X X 0 0 0 8495 0 false false false ROBERT M FREDERICKSON Consulting INC 710 SUMMIT AVE EAST SEATTLE WA 98102 EDITORIAL SERVICEs 172513 EXECUTIVE DIRECTOR INC 555 E WELLS STSTE 1100 MILWAUKEE WI 53202 MANAGEMENT 1529415 BGR GOVERNMENT AFFAIRS LLC 601 THIRTEENTH STREET NW 11TH FL WASHINGTON DC 20005 ADVOCACY 165000 3 1124475 1124475 EXHIBIT REVENUE 900099 391240 391240 JOURNAL INCOME 511120 1780979 1780979 Membership Dues & Assessments 541900 611265 611265 REGISTRATIONS 900099 2439636 2439636 RENTAL INCOME 900099 4000 4000 732 732 5227852 100334 100334 0 0 0 0 0 0 0 ADVERTISING 541900 25200 25200 Job Posting 541900 17002 17002 Miscellaneous 541900 14402 14402 56604 6509265 5259256 25200 100334 X 262500 262500 107356 107356 18774 18774 0 8495 8495 0 0 0 0 0 1529415 838263 691152 19279 5000 14279 6900 6900 0 0 0 568887 550243 18644 151430 102496 48934 195693 53437 142256 124573 88003 36570 0 0 260142 236237 23905 0 1103269 1059126 44143 0 0 32964 32964 15611 13449 2162 REGISTRATION Expense 147505 145910 1595 JOURNAL EXPENSES 106629 106629 DONATIONS 20500 5500 15000 INCOME TAX 4772 4772 7148 5898 1250 4691842 3607316 1084526 0 1324521 2983236 1263453 1788185 20000 60000 395468 578635 0 0 0 0 153692 336711 4893 3762 2363 1131 3872638 3919137 0 0 55533 28800 0 7087668 9695835 301448 189036 770327 1204790 2578 372 1074353 1394198 X 5639315 7886637 374000 415000 6013315 8301637 7087668 9695835 1817423 470899 X false true X true false X 482226 548880 640649 1483553 1735740 4891048 1701307 1999523 2807499 3348315 4616587 14473231 0 0 0 2183533 2548403 3448148 4831868 6352327 19364279 25000 41000 15000 85000 166000 205885 231022 541767 338297 344145 1661116 230885 272022 556767 338297 429145 1827116 17537163 25350 27635 40688 60563 100334 254570 0 25350 27635 40688 60563 100334 254570 9980 10653 13200 22350 25200 81383 500 30 13070 15487 31407 60494 2219363 2586721 3515106 4930268 6509268 19760726 0.88750 0.87770 0.01290 0.01040 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 158984 1875 47143 208002 163601 2326 -6943 158984 129245 6790 27566 163601 107791 8717 12737 129245 100619 6192 980 107791 1.00000 false false false 4893 3762 1131 1131 372 372 X 6980164 470899 470899 6509265 6509265 4691842 4691842 4691842 Part V, Line 4: Intended uses of the endowment fund. The board designated endowment funds are intended to be used in the future to offer research grant(s) to a qualified member(s) of ASGCT. Part X : FIN48 Footnote The Organization is exempt from income tax under Section 501(c)(3) of the Internal Revenue Code and is classified as other than a private foundation. However, income from certain activities, primarily advertising, not directly related to the Organizations tax-exempt purpose is subject to taxation as unrelated business income. As of December 31, 2019, the Organization had a liability of $372 for unrelated business income tax (UBIT). Management has reviewed all tax positions recognized in previously filed tax returns and those expected to be taken in future tax returns. As of December 31, 2019, the Organization had no amounts related to unrecognized income tax benefits and no amounts related to accrued interest and penalties. The Organization does not anticipate any significant changes to unrecognized income tax benefits over the next year. The Organization is currently not under audit by any federal or state taxing authority. true EUROPE 0 0 GRANTS AND OTHER ASSISTANCE RESEARCH AWARDS 2503 EUROPE 0 0 GRANTS AND OTHER ASSISTANCE TRAINEE TRAVEL AWARDS 13600 NORTH AMERICA 0 0 GRANTS AND OTHER ASSISTANCE TRAINEE TRAVEL AWARDS 500 EAST ASIA & THE PACIFIC 0 0 GRANTS & OTHER ASSISTANCE TRAINEE TRAVEL AWARDS 1171 EUROPE 0 0 GRANTS & OTHER ASSISTANCE OUTSTANDING AWARD 1000 18774 18774 OUTSTANDING AWARD EUROPE 1 1000 CHECK FMV RESEARCH AWARDS EUROPE 5 2503 3 WIRE 2 CHECK FMV TRAINEE TRAVEL AWARDS EAST ASIA & PACIFIC 2 1172 WIRE FMV TRAINEE TRAVEL AWARDS EUROPE 2 1100 CHECK FMV TRAINEE TRAVEL AWARDS EUROPE 21 12500 WIRE FMV TRAINEE TRAVEL AWARDS NORTH AMERICA 1 500 CHECK FMV false false false false false false true CHILDRENS HOSPITAL OF PHILAD 3401 CIVIC CENTER BLVD PHILADELPHIA PA 19104 231352166 501(c)(3) 50000 0 FMV CAREER DEVELOPMENT HOUSTON METHODIST RESEARCH IN 6565 FANNIN STREET HOUSTON TX 77030 870721923 501(C)(3) 50000 0 FMV CAREER DEVELOPMENT MARY BYERS INC 315 BRISTOL ROAD CHATHAM IL 62629 262917924 12500 0 FMV STRATEGIC RETREAT HONORARIUM TRUSTEES OF THE UNIVERSITY PA 3451 WALNUT STREET 5TH FL PHILADELPHIA PA 19104 231352685 501(C)(3) 50000 0 FMV CAREER DEVELOPMENT UNIVERSITY OF ARKANSAS PO BOX 1404 FAYETTEVILLE AR 72702 716003252 501(C)(3) 50000 0 FMV CAREER DEVELOPMENT UNIVERSITY OF SOUTHERN CA UNIVERSITY GARDENS STE 205 LOS ANGELES CA 90089 951642394 501(c)(3) 50000 0 FMV CAREER DEVELOPMENT 5 1 RESEARCH AWARDS 10 5000 FMV TRAINEE TRAVEL 90 44356 FMV SPEAKER HONORARIA 2 4000 FMV OUTSTANDING AWARD 2 4000 FMV CAREER Development Awards 1 50000 FMV Grantmaker's Description of How Grants are Used Each year ASGCT gives excellence in research awards to ASGCT Associate Members who received the highest abstract scores of those submitted to the ASGCT Annual Meeting. The scores are given through a peer review process by the Abstract Review Committees. The awardees receive a $500 cash award and travel reimbursement award (up to $500) to attend the Annual Meeting. The Outstanding new Investigator Awards are given to up to four ASGCT active members who have been nominated by two ASGCT active members. The nominees must be seven years or fewer from their first Assistant professorship and be conducting independent research. The nominations are submitted to the ASGCT Advisory Council for consideration. The Advisory Council then submits the recommendation to the ASGCT Board of Directors for approval. The Awardees are given a $1,000 cash award and present their work during the Outstanding New Investigators Symposium at the ASGCT Annual Meeting. The Editor-in-Chief of the Molecular Therapy journal receives a $25,000 stipend and each Deputy Editor receives a $5,000 stipend from ASGCT in the last quarter of each year of the position. The stipend amount is reviewed by the Board during the budgeting process and written into agreement with each new term of the Editor-in-Chief. Form 990, Part III, Line 4d: Other Program Services Description OTHER PROGRAM SERVICES 4: Other programs include: Gene Editing Workshop, Cell Therapy Workshop, Commercialization Workshop, Clinical Trials Training Course, Policy Summit, Career Development Program, Patient Education Program, and the Newsletter. Form 990, Part VI, Line 3: Description of Delegated Duties to Management Company ASGCT IS IN CONTRACT WITH EXECUTIVE DIRECTOR, INC., AN ASSOCIATION MANAGEMENT COMPANY. Form 990, Part VI, Line 6: Explanation of Classes of Members or Shareholder Membership in the Society is dependent on the applicant adequately demonstrating compliance with the requirements for membership as defined in the Bylaws and otherwise by the Board of Directors of the Society. The members of the Society are (a) Members: individuals who have manifested an interest in any discipline important to gene therapy, cell therapy, or manufacturing technologies for gene and cell delivery as evidenced by work in the field, (b) Associate Members: individuals who are currently enrolled in an undergraduate program, postdoctoral fellows program or graduate studies program or who are currently employed as a laboratory manager, technician, assistant, or any other clerical laboratory position in gene and cell therapy research programs are eligible for Associate Membership in the Society (c) Reduced Dues Members: individuals who reside in countries designated as low income or lower-middle income by the World Bank (based on gross national income per capita) and who otherwise fulfill the requirements for Member or Associate Member status shall be eligible for Reduced Dues- Member or Reduced Dues-Associate Member status. (d) Transitional Members: individuals who fulfill the requirements of Member shall be eligible for Transitional Membership for no more than two (2) years, which status provides for the same privileges and member benefits as a Member except that membership dues shall be at a discounted rate as determined by the Board of Directors. (e) Emeritus Members: any Member of the Society who has been in good standing for the most recent three consecutive years, upon attaining age sixty-five (65), and retirement from active practice or research request that his or her membership status be transitioned to Emeritus Membership by making written application to the Chair of the Membership Committee. Form 990, Part VI, Line 7a: How Members or Shareholders Elect Governing Body Active Members in good standing shall be entitled to vote on all matters to be voted on by members of the Society, including, without limitation, electing Officers and Directors of the Society. Any Matter to be decided by a vote of members shall, except as otherwise provided in the bylaws or in Chapter 24.03RCW of the Washington Nonprofit Corporation Act (or any successor provision), be decided by majority vote of members present in person or by proxy at a meeting of the members. Associate Members and Emeritus Members of the Society shall not have voting rights. Form 990, Part VI, Line 7b: Describe Decisions of Governing Body Approval by Members or Shareholders SEE DESCRIPTION IN 7A. Form 990, Part VI, Line 11b: Form 990 Review Process THE FORM 990 AND ALL REQUIRED SCHEDULES ARE PROVIDED TO THE FINANCE COMMITTEE AND BOARD OF DIRECTORS FOR REVIEW AND APPROVAL. ONCE APPROVED THE FORM IS SIGNED BY THE APPROPRIATE OFFICER AND FILED WITH THE IRS. Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of Conflicts Prior to each meeting of the Board of Directors, each Director is asked to review the meeting agenda and meeting materials. After reviewing, each Director is asked to disclose any conflict of interest to the Society's Executive Director. The Executive Director discusses the conflict with the Executive Committee to determine the appropriate remedial action based on the disclosed conflict. Speakers presenting at a Society meeting are required to fill out a disclosure document and a facultycompliance document prior to speaking. The documents are reviewed by the Society. Any speakers who have a conflict are also required to submit their presentation slides for review and include a disclosure slide prior to their presentation so that the audience is aware of the relationships they have to disclose. The Society produces and distributes to each program attendee a printed disclosure document that complies any disclosures of every faculty member. The Society also distributes two surveys at each program: one to the chair of the session and one to each audience member which asks them to indicate if the presentations by any of the faculty contained bias. Form 990, Part VI, Line 15a: Compensation Review & Approval Process - CEO, Top Management ASGCT is managed by Executive Director Incorporated, a for-profit management company. ASGCT Has no official employees because all staff assigned to ASGCT are employees of the management company. ASGCT does not compensate Directors or other top officials. ASGCT also does not have anybody that fits the definition of a key employee. Form 990, Part VI, Line 15b: Compensation Review and Approval Process for Officers and Key Employees SEE 15A. Form 990, Part VI, Line 19: Other Organization Documents Publicly Available ASGCT makes its governing documents, conflict of interest policy, and Form 990/990-T available for public inspection upon request. All such requests should be in writing and accompanied by a $20 reproduction and handling charge if print copy is requested. Members of the Board receiving an inquiry must advise staff of the request within a reasonable time after the inquiry is received. The Bylaws can also be found on the ASGCT website.